Stockreport

MAIA's Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates [Yahoo! Finance]

MAIA Biotechnology, Inc.  (MAIA) 
PDF by MAIA Biotechnology (NYSE American: MAIA), appears to be gaining increasing attention in the oncology community as emerging clinical results continue to surpass expect [Read more]